Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 401 of 5804
-
New combo attack on sarcoma aims to delay return of cancer
Disease control Recruiting nowThe goal of this clinical research study is to look at the effectiveness of giving a combination of chemotherapy, immunotherapy, radiation therapy, and surgery to treat soft tissue sarcomas that can be removed by surgery. Researchers want to find out if this treatment combination…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New 24-Strain pneumonia vaccine trial launches for kids
⭐️ VACCINE ⭐️ Recruiting nowThe Phase II clinical trial of the 24-valent pneumococcal polysaccharide conjugate vaccine (RZ700) will be carried out in infants and young children aged 2 months (minimum 6 weeks) to 71 months. The purpose of this study is to evaluate the immunogenicity and safety of the 24-vale…
Phase: PHASE2 • Sponsor: Shanghai Reinovax Biologics Co.,LTD • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:11 UTC
-
Personalized mRNA vaccine shows promise for biliary cancer patients
Disease control Recruiting nowThe primary objective of this study is to evaluate the safety of iNeo-Vac-R01, an individualized mRNA therapeutic technology based on tumor neoantigens, for the adjuvant treatment of patients with biliary malignant tumors after radical resection.
Phase: PHASE1, PHASE2 • Sponsor: Yifan Wang • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Head-to-Head: which drug works best for stubborn Crohn's?
Disease control Not yet recruitingCrohn's disease is a chronic inflammatory bowel disorder characterized primarily by abdominal pain and diarrhea \[1,2\]. Conventional treatments include corticosteroids and immunosuppressants (such as azathioprine, mercaptopurine, and methotrexate) \[2,3\]. The introduction of an…
Phase: PHASE3 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 26, 2026 13:11 UTC
-
New drug combo aims to stop esophageal cancer relapse in phase 3 trial
Disease control Recruiting nowDefinitive chemoradiotherapy (CRT) is the standard treatment for locally advanced unresectable esophageal cancer, but its efficacy remains unsatisfactory. More importantly, there is a lack of effective consolidation treatment after CRT, resulting in a high recurrence rate. Our pr…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy aims to keep advanced breast cancer in check longer
Disease control Not yet recruitingThis is a phase II trial exploring the maintenance therapy with trastuzumab combined with pyrotinib or dalpiciclib and endocrine therapy in HER2-positive advanced breast cancer based on different hormone receptor (HR) statuses following trastuzumab rezetecan (T-DXh, SHR-A1811) as…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 26, 2026 18:20 UTC
-
New heart zapping device could offer safer fix for irregular heartbeat
Disease control Recruiting nowTo evaluate the safety and effectiveness of the Argá Medtech CSE Ablation System in the treatment of atrial fibrillation.
Phase: NA • Sponsor: Arga Medtech SA • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Surgery before chemo and immunotherapy may boost lung cancer outcomes
Disease control Not yet recruitingThis study aims to evaluate whether resecting the primary tumor can improve the outcomes of treatment with sintilimab and chemotherapy in advanced EGFR/ALK-negative non-small cell lung cancer (NSCLC). Patients will be randomly assigned to one of two groups: one group will undergo…
Phase: PHASE2 • Sponsor: Jianxing He • Aim: Disease control
Last updated Jun 26, 2026 18:22 UTC
-
New H5N8 bird flu vaccine enters human trials
⭐️ VACCINE ⭐️ Recruiting nowThis study aims to demonstrate the safety and immunogenicity of two formulations of the monovalent influenza vaccine candidate A (H5N8) (inactivated, fragmented, and adjuvanted with IB160) from the Instituto Butantan in adults and older adults, to be developed for situations of p…
Phase: PHASE1, PHASE2 • Sponsor: Butantan Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:03 UTC
-
New combo therapy targets hard-to-treat sarcoma
Disease control Recruiting nowA phase 2 study assessing the efficacy of all-trans retinoic acid (ATRA) and Cemiplimab in patients with metastatic/locally advanced - unresectable leiomyosarcoma (LMS) who have progressed standard-of-care therapy. Patients will be enrolled in cohorts according to a Bayesian Opti…
Phase: PHASE2 • Sponsor: Gabriel Tinoco • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Radio waves plus targeted drug aim to extend life in tough-to-treat colon cancer
Disease control Recruiting nowThe goal of this clinical trial is to learn if adding amplitude-modulated radiofrequency electromagnetic fields (AM RF EMF) to Fruquintinib in metastatic colorectal cancer that has not responded to other standard treatment is: * Effective in improving survival * safe and tolerab…
Phase: PHASE2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could old drugs beat long COVID? new trial aims to find out
Symptom relief Recruiting nowThe Long-Covid (LC)-Revitalize clinical study is testing repurposed drug treatments for Long Covid, involving adult participants from Brazil, Canada, Italy, Uganda, the United States, and Zambia. To qualify, participants must have had Covid-19 and experienced Long Covid symptoms …
Phase: PHASE3 • Sponsor: Douglas D. Fraser • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Could MDMA help treat OCD? new study investigates
Symptom relief Recruiting nowThe study assesses the safety and preliminary effectiveness of MDMA-assisted cognitive behavioral therapy in participants diagnosed with obsessive-compulsive disorder (OCD).
Phase: PHASE2 • Sponsor: Carolyn Rodriguez • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New drug aims to reduce bulging eyes in thyroid disease
Disease control Recruiting nowA multicenter clinical study to evaluate the efficacy and safety of IBI311 in subjects with inactive thyroid eye disease. The study consists of two parts, with a maximum duration of approximately 64 weeks.
Phase: PHASE3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug cocktail aims to tackle tough lymphoma
Disease control Recruiting nowThis multicenter, open-label, trial aims to evaluate the efficacy and safety of orelabrutinib plus lisaftoclax and rituximab in patients with high-risk mantle cell lymphoma (MCL). The primary objective is to assess the optimal complete response (CR) rate during the induction phas…
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Ultrasound helmet aims to wake the brain after severe injury
Disease control Recruiting nowThe main questions this study aims to answer are: Can low-intensity FUS neuromodulation be safely and feasibly administered to the bilateral central thalamus in patients with disorders of consciousness (DoC)? Does FUS neuromodulation result in short-term improvements in arousal …
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could a pacemaker plus ablation beat pills for heart failure patients with AFib?
Disease control Recruiting nowThe goal of this clinical trial is to assess the clinical efficacy of physiological pacing combined with atrioventricular node ablation, in patients with Heart Failure with preserved Ejection Fraction (HFpEF) and well controlled permanent atrial fibrillation.The main question it …
Phase: NA • Sponsor: French Cardiology Society • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Gene therapy shot into both eyes aims to save sight in rare blindness
Disease control OngoingThe purpose of this Phase 2 Study is to see if the investigational study drug, laruparetigene zovaparvovec, also known as AGTC-501, given in both eyes, is safe and works to preserve and/or improve vision and other symptoms of XLRP.
Phase: PHASE2 • Sponsor: Beacon Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for kids with rare GNAO1 epilepsy: experimental drug trial launches
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of the investigational drug ASO-GNAO1 (Tianasen) in pediatric patients with c.607G\>A mutation in the GNAO1 gene associated with epilepsy and neurodevelopmental disorder. The main questions it aims to answer a…
Phase: PHASE1, PHASE2 • Sponsor: Pirogov Russian National Research Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for stem cell transplant patients with severe immune complication
Disease control Recruiting nowThe purpose of the study is to assess the efficacy and safety of ruxolitinib in Chinese adult and pediatric participants aged 12 years or older with corticosteroid-refractory chronic graft vs. host disease (SR-cGvHD).
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC